ME/CFS: brief improvement from oxaloacetate trial, then relapsed
- Condition
- ME/CFS
- At worst
- Not stated
- Ill before improving or writing
- Not stated
- Last post
- Jan 2026
In their words
- Now: Relapsed
Amazing results, unfortunately due to price I have not been able to take it daily or long term.
In context ↗
Read from 1 of their posts and comments; links to the one this page draws on
Summary
They used oxaloacetate only for a test trial and reported amazing, life-changing results, saying it gave them a snippet of being healthy. The cost meant they could not take it daily or over the long term, so the improvement was brief rather than sustained. They described the experience as a short taste of health and did not continue the treatment beyond the trial.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- oxaloacetate · Helped a lot
I used it for a test trial. Amazing results, unfortunately due to price I have not been able to take it daily or long term.
In context ↗
Approaches: Supplements
Ask Miruvor AI
Similar stories
-
Long COVID then ME/CFS, still lying down half the day, credits hard rest
A US scientist and former endurance cyclist who fell ill with long COVID in August 2023 and was later diagnosed with ME/CFS. They tried antivirals, nicotine patches, triple anticoagulants, LDN, antihistamines and malate, but credited hard rest most; nicotine…
-
Moderate bordering on severe ME/CFS, much better with low-dose naltrexone and oxaloacetate
She fell ill around 2016, was moderate for six months, then mild for years before declining to moderate bordering on severe by 2025 after a hard postpartum with COVID and 24/7 childcare. Low-dose naltrexone at 6mg nightly largely stopped months of rolling…
-
Largely bedbound with ME/CFS, improved on ivabradine and LDN then relapsed
Oak 32031 was diagnosed with ME/CFS in 2008 at age 20 and declined from mild to severe, becoming largely bedbound, using a powerchair outdoors and giving up work in 2015. Methylation supplements gave early gains; much later ivabradine for POTS and low-dose…
-
Extremely severe ME/CFS for five months, now much better after low-dose Abilify
Mild ME/CFS from late 2021; in February 2025 they crashed to extremely severe for five months, unable to speak or tolerate light or noise. Low-dose Abilify, dextromethorphan, a COVID infection, nicotinamide riboside and oxaloacetate from August 2025 brought…